Contact Us  +(1) 855 8KRANE8  info@kraneshares.com
KraneShares Events

Please register to attend this event

Live Webcast: China Healthcare – Opportunities From One Of The Fastest Growing Major Global Healthcare Markets

* indicates required

Are you a financial professional? *

When: Thursday, June 21, 2018
11:00am – 12:00pm EST
What:

Live Webinar: China Healthcare – Opportunities From One of The Fastest Growing Major Global Healthcare Markets

  • China currently has the fastest growing major healthcare market in the world with a five-year compound annual growth rate of 17%, compared to just 4% in the United States, and -2% in Japan.1
  • China is the second largest healthcare market globally with total healthcare expenditure reaching $594 billion in 20151. A number projected to reach $1.1 trillion by 20202.
  • There is still opportunity for considerable growth in China’s healthcare market with per capita health spending at just $420, compared to an average of over $5,800 for the world’s top eight healthcare markets in terms of per capita expenditure.3
  • China’s aging population, rising incomes and increasing urbanization may provide a sustained catalyst for growth in China’s healthcare sector.

During the webinar we will dicuss:

  • China's healthcare ecosystem including: patent and generic pharmaceuticals, hospital administration, biotechnology, medical equipment production, healthcare IT, and traditional Chinese medicine.
  • Companies that benefit from China's growing middle class, aging population, favorable policies and other growth trends.
  • Potential benefits of the KraneShares MSCI All China Health Care Index ETF (Ticker: KURE) for portfolios.

1.) Major healthcare markets defined as top five global markets by the World Health Organization. Data from the World Health Organization as of 12/31/2015 retrieved 01/29/2018
2.) International Trade Association, "2016 Top Markets Report Pharmaceuticals, 2016". Retrieved 01/26/2018.
3.) Data from IMS Market Prognosis, 10/2016

About the Speakers

 
brendan_ahern
Brendan Ahern
Chief Investment Officer

Brendan is the Chief Investment Officer (CIO) at KraneShares where he is in charge of the firm’s research, education and investor outreach efforts. He was an early pioneer of the US exchange traded fund (ETF) industry as one of the first 20 employees of iShares by BlackRock. During his tenure at iShares he saw AUM grow from a few billion to $800 Billion.

Brendan is considered a preeminent expert in global financial markets with a particular focus on China, and is often sought after by leading business and financial outlets including CNBC, Bloomberg, The Wall Street Journal and Investor’s Business Daily.

Brendan graduated from the College of the Holy Cross and has a Master of Science in Financial Analysis from the University of San Francisco.

Xiaolin Chen
Dr. Xiaolin Chen
Global Head of Investment Solutions and Strategies at KraneShares

Xiaolin is a Managing Director, Global Head of Investment Solutions and Strategies of KraneShares based in London. Prior to joining the firm, Xiaolin was a lead portfolio manager with J.P.Morgan Private Bank managing fund of fund portfolios comprising public market and liquid alternative assets. Xiaolin was responsible for client portfolios totaling $70 billion collectively across a range of different risk parameters. Her duties included development of investment strategy, tactical asset allocation and investment implementation.

Xiaolin holds a Bachelor’s Degree and Ph.D. in Computer Science, both obtained from the University of Nottingham, the United Kingdom.

Mark Schlarbaum
Mark Schlarbaum
Managing Partner – Head of Capital Markets / Portfolio Manager

Mark joined KraneShares in October 2015 as a Managing Partner, portfolio manager and global head of trading. Mark has over 23 years of investment experience consisting of equity trading in both international and domestic markets as well as managing diversified investment portfolios for some of the largest advisory platforms in the U.S. He previously worked for T. Rowe Price for 7 years where he was responsible for trading over $40 billion of assets consisting of domestic and international equities, options and futures. In 2003, Mark left T. Rowe price to pursue his own successful entrepreneurial endeavors, which ranged from managing equity long-short portfolios to domestic small cap long-only separately managed accounts (SMAs), the latter of which grew to over $400 million AUM.